Study of COVID-19 vaccine begins in adolescents
Moderna Inc said on Thursday it had dosed the first participant in a mid-to-late stage study testing its COVID-19 vaccine candidate in adolescents aged 12 to less than 18. The study is being conducted in collaboration with the Biomedical Advanced Research and Development Authority (BARDA). “Our goal is to generate data in the spring of […]




